NCT02771093View on ClinicalTrials.gov

An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 8, 2016

Primary Completion Date

April 27, 2017

Study Completion Date

April 27, 2017

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Trelagliptin

Trelagliptin 100 mg tablet

DRUG

Alogliptin

Alogliptin 25 mg tablet

Trial Locations (1)

Unknown

Naka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY